Volastra licenses Amgen molecule for chromosomally unstable cancers By / On March 7, 2023 / At 7:06 pm / In Chemical world 7 Views Start-up also brings in $60 million series A Post navigation Prev PostC&EN Methods: 5 lessons from a year of implementing the ACS Inclusivity Style Guide Next PostFrench National Center for Scientific Research faulted over chemistry lab misconduct probe You May Also Like Editing the structure of molecules On March 27, 2023 | In Chemical world Regenerative engineering: Polymeric chemistry and materials science for regeneration On March 26, 2023 | In Chemical world Periodic Graphics: Making molecular sandwiches On March 26, 2023 | In Chemical world
By 
